NCT01572727
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01572727
Title A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation
Acronym BELLE-4
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | ITA | ISR | HUN | GBR | FRA | ESP | DEU | CZE | CAN | BRA | BEL | AUT | AUS

Facility Status City State Zip Country Details
Ironwood Cancer and Research Centers SC Chandler Arizona 85224 United States Details
Arizona Oncology Associates Dept of Oncology Phoenix Arizona United States Details
Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville Arkansas 72703 United States Details
California Cancer Care Marian Speciality Greenbrae California 94904 United States Details
Rocky Mountain Cancer Centers RMCC Hale Pkwy Greenwood Village Colorado United States Details
H. Lee Moffitt Cancer Center & Research Institute SC Tampa Florida 33612 United States Details
Emory University School of Medicine/Winship Cancer Institute Dept.of WinshipCancerInst. (2) Atlanta Georgia 30322 United States Details
Northwest Georgia Oncology Center NW Georgia Onc Marietta Georgia 30060 United States Details
University of Kansas Cancer Center Univ Kansas 2 Kansas City Kansas 66160 United States Details
Norton Healthcare, Inc. Louisville Kentucky 40202 United States Details
Washington University School of Medicine Regulatory St Louis Missouri 63110 United States Details
University of Nebraska Medical Center Unv Nebraska Med Ctr (2) Omaha Nebraska 68198 United States Details
University of New Mexico Cancer Research Center Dept of Univ New Mexico Albuquerque New Mexico 87131 United States Details
New York Oncology Hematology, P.C. Dept. of New York Oncology. PC Troy New York 12180 United States Details
Ohio State Comprehensive Cancer Center/James Cancer Hospital SC-1 Columbus Ohio 43210 United States Details
University of Oklahoma Health Sciences Center OUHSC 2 Oklahoma City Oklahoma 73104 United States Details
Northwest Cancer Specialists Vancouver Loc Portland Oregon 97210 United States Details
Baylor Health Care System/Sammons Cancer Center Baylor Texas Oncology Dallas Texas 75246 United States Details
University of Texas Southwestern Medical Center Harry Hines Dallas Texas 75390 United States Details
Cancer Care Centers of South Texas / HOAST CCC of So. TX- San Antonio San Antonio Texas 78229 United States Details
Medical Oncology & Hematology Associates of Northern VA Med Onc Hem Northern VA Reston Virginia 20190 United States Details
Novartis Investigative Site Sydney New South Wales 2060 Australia Details
Novartis Investigative Site Geelong Victoria 3220 Australia Details
Novartis Investigative Site Parkville Victoria 3050 Australia Details
Novartis Investigative Site Nedlands Western Australia 6009 Australia Details
Novartis Investigative Site Salzburg 5020 Austria Details
Novartis Investigative Site Vienna A-1090 Austria Details
Novartis Investigative Site Charleroi 6000 Belgium Details
Novartis Investigative Site Liège 4000 Belgium Details
Novartis Investigative Site Ottignies 1340 Belgium Details
Novartis Investigative Site Sint-Niklaas 9100 Belgium Details
Novartis Investigative Site Wilrijk 2610 Belgium Details
Novartis Investigative Site Fortaleza Ceará 60336-045 Brazil Details
Novartis Investigative Site São Paulo São Paulo 01221-020 Brazil Details
Novartis Investigative Site São Paulo São Paulo 01246-000 Brazil Details
Novartis Investigative Site São Paulo São Paulo 01317-002 Brazil Details
Novartis Investigative Site Montreal Quebec H4A 3J1 Canada Details
Novartis Investigative Site Brno Czech Republic 656 53 Czechia Details
Novartis Investigative Site Olomouc 775 20 Czechia Details
Novartis Investigative Site Prague 128 08 Czechia Details
Novartis Investigative Site Angers 49055 France Details
Novartis Investigative Site Bordeaux 33076 France Details
Novartis Investigative Site Créteil 94010 France Details
Novartis Investigative Site La Roche-sur-Yon 85925 France Details
Novartis Investigative Site Le Mans 72015 France Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Nice 06189 France Details
Novartis Investigative Site Saint-Herblain 44805 France Details
Novartis Investigative Site Toulouse 31059 France Details
Novartis Investigative Site Villejuif 94805 France Details
Novartis Investigative Site Bonn 53111 Germany Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Erlangen 91054 Germany Details
Novartis Investigative Site Frankfurt 60389 Germany Details
Novartis Investigative Site Fulda 36043 Germany Details
Novartis Investigative Site Mainz 55131 Germany Details
Novartis Investigative Site München 80637 Germany Details
Novartis Investigative Site Ravensburg 88214 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Hong Kong SAR Hong Kong Details
Novartis Investigative Site Budapest 1134 Hungary Details
Novartis Investigative Site Debrecen 4032 Hungary Details
Novartis Investigative Site Szolnok H-5000 Hungary Details
Novartis Investigative Site Ramat Gan 5266202 Israel Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Cona FE 44100 Italy Details
Novartis Investigative Site Genova GE 16132 Italy Details
Novartis Investigative Site Monza MB 20900 Italy Details
Novartis Investigative Site Messina ME 98158 Italy Details
Novartis Investigative Site Milan MI 20141 Italy Details
Novartis Investigative Site Nagoya Aichi-ken 464-8681 Japan Details
Novartis Investigative Site Nagoya Aichi-ken 467-8602 Japan Details
Novartis Investigative Site Sapporo Hokkaido 135-8550 Japan Details
Novartis Investigative Site Isehara Kanagawa 259-1193 Japan Details
Novartis Investigative Site Kawasaki Kanagawa 216-8511 Japan Details
Novartis Investigative Site Yokohama Kanagawa 241-8515 Japan Details
Novartis Investigative Site Kumamoto Kumamoto 860-8556 Japan Details
Novartis Investigative Site Osaka Osaka 537-8511 Japan Details
Novartis Investigative Site Osaka Osaka 540-0006 Japan Details
Novartis Investigative Site Suita Osaka 565-0871 Japan Details
Novartis Investigative Site Koto Tokyo 135-8550 Japan Details
Novartis Investigative Site Breda Netherlands 4819 EV Netherlands Details
Novartis Investigative Site Rotterdam 3075 EA Netherlands Details
Novartis Investigative Site Saint Petersburg Russia 197022 Russia Details
Novartis Investigative Site Saint Petersburg 197758 Russia Details
Novartis Investigative Site Singapore Singapore 119228 Singapore Details
Novartis Investigative Site Johannesburg 2196 South Africa Details
Novartis Investigative Site Seoul Korea 03080 South Korea Details
Novartis Investigative Site Seoul Korea 05505 South Korea Details
Novartis Investigative Site Seoul Korea 06351 South Korea Details
Novartis Investigative Site Córdoba Andalusia 14004 Spain Details
Novartis Investigative Site Málaga Andalusia 29010 Spain Details
Novartis Investigative Site Seville Andalusia 41013 Spain Details
Novartis Investigative Site Barcelona Catalonia 08003 Spain Details
Novartis Investigative Site Barcelona Catalonia 08036 Spain Details
Novartis Investigative Site L'Hospitalet de Llobregat Catalonia 08907 Spain Details
Novartis Investigative Site A Coruña Galicia 15009 Spain Details
Novartis Investigative Site Madrid Madrid 28007 Spain Details
Novartis Investigative Site Madrid Madrid 28033 Spain Details
Novartis Investigative Site Madrid Madrid 28034 Spain Details
Novartis Investigative Site Madrid Madrid 28040 Spain Details
Novartis Investigative Site San Cristóbal de La Laguna Santa Cruz de Tenerife 38320 Spain Details
Novartis Investigative Site Valencia Valencia 46009 Spain Details
Novartis Investigative Site Valencia Valencia 46010 Spain Details
Novartis Investigative Site Zaragoza Zaragoza 50009 Spain Details
Novartis Investigative Site Taipei Taiwan 10048 Taiwan Details
Novartis Investigative Site Kuei-Shan Chiang Taoyuan/ Taiwan ROC 33305 Taiwan Details
Novartis Investigative Site New Taipei City 23561 Taiwan Details
Novartis Investigative Site Maidstone Kent M16 9QQ United Kingdom Details
Novartis Investigative Site Glasgow - Scotland G12 OYN United Kingdom Details
Novartis Investigative Site London United Kingdom Details
Novartis Investigative Site Metropolitan Borough of Wirral CH63 3JY United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field